Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

All NewsSeptember 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today’s pre-market trading.

Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent